Home -
Products -
Chromatin/Epigenetic -
Epigenetic Reader Domain -
SMARCA-BD ligand 1 for Protac dihydrochloride
SMARCA-BD ligand 1 for Protac dihydrochloride
CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride( —— )
Catalog No. M33234 CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 93 | Get Quote |
|
| 5MG | 140 | Get Quote |
|
| 10MG | 227 | Get Quote |
|
| 25MG | 364 | Get Quote |
|
| 50MG | 523 | Get Quote |
|
| 100MG | 700 | Get Quote |
|
| 500MG | 1413 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSMARCA-BD ligand 1 for Protac dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
-
DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2369053-68-7
-
Formula Weight344.24
-
Molecular FormulaC14H19Cl2N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2.7 mg/mL (7.84 mM; Ultrasonic (<60°C)
-
SMILESCl.Cl.Nc1nnc(cc1N1CCNCC1)-c1ccccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.?
molnova catalog
related products
-
GSK8573
GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).
-
DW71177
DW71177 is a bd1-selective and potent BET inhibitor with potent anti-leukemic activity for the study of leukemia.
-
CCT077791
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Cart
sales@molnova.com